Utility of CD8 score by automated quantitative image analysis in head and neck squamous cell carcinoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Utility of CD8 score by automated quantitative image analysis in head and neck squamous cell carcinoma

Published:2018-11 Issue: Volume:86 Page:278-287
ISSN:1368-8375
Container-title:Oral Oncology
language:en
Short-container-title:Oral Oncology

Author:

Hartman Douglas J.,Ahmad Fahad,Ferris Robert L.,Rimm David L.,Pantanowitz Liron

Funder

Yale SPORE

Yale Cancer Center Support Grant

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Oral Surgery

Reference26 articles.

1. Implications of the tumor immune microenvironment for staging and therapeutics;Taube;Mod Pathol,2018

2. Dose-response association of CD8+ tumor-infiltrating lymphocytes and survival time in high-grade serous ovarian cancer;Goode;JAMA Oncol,2017

3. Targeting CD8+ T-cell tolerance for cancer immunotherapy;Jackson;Immunotherapy,2014

4. CD8+ T-cell memory in tumor immunology and immunotherapy;Klebanoff;Immunol Rev,2006

5. CD8+ tumour-infiltrating lymphocytes in relation to HPV status and clinical outcome in patients with head and neck cancer after postoperative chemoradiotherapy: a multicentre study of the German cancer consortium radiation oncology group (DKTK-ROG);Balermpas;Int J Cancer,2016

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The pathogenic response of cytotoxic T‑lymphocytes, a common therapeutic target for cancer, has a direct impact on treatment outcomes (Review);Oncology Reports;2024-06-17

2. Automated Quantitative CD8+ Tumor-Infiltrating Lymphocytes and Tumor Mutation Burden as Independent Biomarkers in Melanoma Patients Receiving Front-Line Anti-PD-1 Immunotherapy;The Oncologist;2024-04-24

3. Neoadjuvant Vidutolimod and Nivolumab in High-Risk Resectable Melanoma;2024

4. Comparison of FNA-based conventional cytology specimens and digital image analysis in assessment of pancreatic lesions;Cytojournal;2023-10-09

5. Safety of Nivolumab Added to Chemoradiation Therapy Platforms for Intermediate and High-Risk Locoregionally Advanced Head and Neck Squamous Cell Carcinoma: RTOG Foundation 3504;International Journal of Radiation Oncology*Biology*Physics;2023-03

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3